Despite a lowered price target from UBS from $122 to $117 due to cost pressures from the Willow project, the firm maintained its Buy rating and optimistic forecast. The company is described as one of the most undervalued and one of the 12 best commodity stocks to buy. However, its share price has declined roughly 13% year-to-date, pressured by softer oil prices linked to geopolitical ceasefire speculation and a broader market rotation away from the energy sector.